Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjeev K Upadhyay

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Physiology|June 17, 2009
Potassium channel opening: a subtle two-stepSanjeev K Upadhyay, P Nagarajan, M K Mathew
Frontiers in Endocrinology|February 19, 2026
Obesity and type 2 diabetes as chronic inflammation: how does the cytokine evidence align?Karishma Bhatia, Vikas Kumar Gupta, Sanjeev K Upadhyay
Journal of Biosciences|August 9, 2024
An <i>in vitro</i> model of adipose tissue-associated macrophagesKarishma Bhatia, Sandhya Tiwari, Vikas Kumar Gupta, et al.
Frontiers in Molecular Biosciences|April 3, 2025
<i>Sida cordifolia</i> is efficacious in models of Huntington's disease by reducing ER stressPrasanna K Simha, Chandramouli Mukherjee, Vikas Kumar Gupta, et al.
Nature|April 18, 2008
Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteinsAbbhirami Rajagopal, Anita U Rao, Julio Amigo, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 27, 2011
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesVictor Chi, Michael W Pennington, Raymond S Norton, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2012
Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune diseaseEric J Tarcha, Victor Chi, Ernesto J Muñoz-Elías, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 4, 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesSandeep Chhabra, Shih Chieh Chang, Hai M Nguyen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Physiology|June 17, 2009
Potassium channel opening: a subtle two-stepSanjeev K Upadhyay, P Nagarajan, M K Mathew
Frontiers in Endocrinology|February 19, 2026
Obesity and type 2 diabetes as chronic inflammation: how does the cytokine evidence align?Karishma Bhatia, Vikas Kumar Gupta, Sanjeev K Upadhyay
Journal of Biosciences|August 9, 2024
An <i>in vitro</i> model of adipose tissue-associated macrophagesKarishma Bhatia, Sandhya Tiwari, Vikas Kumar Gupta, et al.
Frontiers in Molecular Biosciences|April 3, 2025
<i>Sida cordifolia</i> is efficacious in models of Huntington's disease by reducing ER stressPrasanna K Simha, Chandramouli Mukherjee, Vikas Kumar Gupta, et al.
Nature|April 18, 2008
Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteinsAbbhirami Rajagopal, Anita U Rao, Julio Amigo, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 27, 2011
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesVictor Chi, Michael W Pennington, Raymond S Norton, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2012
Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune diseaseEric J Tarcha, Victor Chi, Ernesto J Muñoz-Elías, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 4, 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesSandeep Chhabra, Shih Chieh Chang, Hai M Nguyen, et al.
Pageof 1